Assyro AI

Orange Book product · Brand (NDA)

NEURACEQ

FLORBETABEN F-18

Brand (NDA)NDA 204677RX LANTHEUS

At a glance

Mar 19, 2014

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 19, 2014

    12 yr 5 mo ago

  2. Today

  3. Patent 7807135 expires

    Listed drug substance patent expiration.

    Mar 18, 2029

    in 2 yr 9 mo

  4. Patent 9308284 expires

    Listed drug product patent expiration.

    Jul 14, 2032

    in 6 yr 2 mo

Pharmaceutical detail

Active ingredient

FLORBETABEN F-18

Strength

1.4-135mCi/ML

Dosage form

SOLUTION

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 204677

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7807135Mar 18, 2029in 2 yr 9 mo
SubstanceProductU-1497
9308284Jul 14, 2032in 6 yr 2 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.